BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 17014881)

  • 1. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.
    Colmenero P; Berglund P; Kambayashi T; Biberfeld P; Liljeström P; Jondal M
    Gene Ther; 2001 Sep; 8(17):1307-14. PubMed ID: 11571567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death.
    Kohno A; Emi N; Kasai M; Tanimoto M; Saito H
    Gene Ther; 1998 Mar; 5(3):415-8. PubMed ID: 9614563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
    Daemen T; Riezebos-Brilman A; Regts J; Dontje B; van der Zee A; Wilschut J
    Antivir Ther; 2004 Oct; 9(5):733-42. PubMed ID: 15535411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
    Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
    Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system.
    Fujiyama K; Saejung W; Yanagihara I; Nakado J; Misaki R; Honda T; Watanabe Y; Seki T
    J Biosci Bioeng; 2006 May; 101(5):398-402. PubMed ID: 16781468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.
    de Mare A; Lambeck AJ; Regts J; van Dam GM; Nijman HW; Snippe H; Wilschut J; Daemen T
    Gene Ther; 2008 Mar; 15(6):393-403. PubMed ID: 18004406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
    Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
    Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coat protein interactions involved in tobacco mosaic tobamovirus cross-protection.
    Lu B; Stubbs G; Culver JN
    Virology; 1998 Sep; 248(2):188-98. PubMed ID: 9721228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
    Withoff S; Glazenburg KL; van Veen ML; Kraak MM; Hospers GA; Störkel S; de Vries EG; Wilschut J; Daemen T
    Gene Ther; 2001 Oct; 8(20):1515-23. PubMed ID: 11704811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
    Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
    Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.
    McCormick AA; Corbo TA; Wykoff-Clary S; Nguyen LV; Smith ML; Palmer KE; Pogue GP
    Vaccine; 2006 Sep; 24(40-41):6414-23. PubMed ID: 16860441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of recombinant alphaviral vectors.
    Lundstrom K
    Cold Spring Harb Protoc; 2012 Jul; 2012(7):825-31. PubMed ID: 22753600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon.
    Pan Y; Zhao Q; Fang L; Luo R; Chen H; Xiao S
    J Gene Med; 2009 Nov; 11(11):1030-8. PubMed ID: 19757479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of surface plasmon resonance imaging to study viral RNA: protein interactions.
    Garcia BH; Goodman RM
    J Virol Methods; 2008 Jan; 147(1):18-25. PubMed ID: 17875327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.
    Zhang J; Asselin-Paturel C; Bex F; Bernard J; Chehimi J; Willems F; Caignard A; Berglund P; Liljeström P; Burny A; Chouaib S
    Gene Ther; 1997 Apr; 4(4):367-74. PubMed ID: 9176524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors.
    Shivprasad S; Pogue GP; Lewandowski DJ; Hidalgo J; Donson J; Grill LK; Dawson WO
    Virology; 1999 Mar; 255(2):312-23. PubMed ID: 10069957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.